BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
eris lifesciences limited stock

ERIS LIFESCIENCES LIMITED Share Price

1475 -37.90 (-2.50%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: ERIS

ERIS LIFESCIENCES LIMITED Share Price Update

As of the latest trading session, ERIS LIFESCIENCES LIMITED share price is currently at 1475, which is down by -37.90 from its previous closing. Today, the stock has fluctuated between 1445.05 and 1516.00. Over the past year, ERIS LIFESCIENCES LIMITED has achieved a return of 68.44 %. In the last month alone, the return has been 10.21 %. Read More...

ERIS LIFESCIENCES LIMITED Performance

Day Range

Low1445.05 High1516.00
1464.95

52 Week Range

Low 809.15 High 1593.90
1464.95

ERIS LIFESCIENCES LIMITED Share Price

21154

540596

ERIS

img img img img
No Data Available

Open Price

1516.00

Prev. Close

1512.90

Volume (Shares)

123796.00

Total traded value

1813.54

Upper Circuit

1815.45

Lower Circuit

1210.35

Note: The current prices & values are delayed, Login to your account for live updates.

ERIS LIFESCIENCES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 20064.17
PE Ratio (TTM) 171.63
Book Value / Share 189.32
Beta 0.35
ROE 12.63%
EPS (TTM) 8.55
Dividend Yield 0.00%
Net Profit Qtr (Cr) 28.10

ERIS LIFESCIENCES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 428.75
Operating Expense 396.34
Net Profit 28.10
Net Profit Margin (%) 6.55
Earnings Per Share (EPS) 2.06
EBITDA 148.44
Effective Tax Rate (%) 38.93
Particulars JUN 2024 (Values in Cr)
Revenue 449.17
Operating Expense 435.03
Net Profit 17.04
Net Profit Margin (%) 3.79
Earnings Per Share (EPS) 1.25
EBITDA 128.54
Effective Tax Rate (%) 36.46
Particulars MAR 2024 (Values in Cr)
Revenue 332.25
Operating Expense 319.94
Net Profit 39.51
Net Profit Margin (%) 11.89
Earnings Per Share (EPS) 2.90
EBITDA 99.78
Effective Tax Rate (%) 5.36
Particulars DEC 2023 (Values in Cr)
Revenue 315.96
Operating Expense 293.20
Net Profit 31.66
Net Profit Margin (%) 10.02
Earnings Per Share (EPS) 2.33
EBITDA 77.86
Effective Tax Rate (%) 8.63
Particulars SEP 2023 (Values in Cr)
Revenue 402.26
Operating Expense 296.77
Net Profit 117.81
Net Profit Margin (%) 29.28
Earnings Per Share (EPS) 8.66
EBITDA 151.47
Effective Tax Rate (%) 1.75
Particulars MAR 2024 (Values in Cr)
Revenue 1454.75
Operating Expense 1192.70
Net Profit 299.72
Net Profit Margin (%) 20.60
Earnings Per Share (EPS) 22.04
EBITDA 488.65
Effective Tax Rate (%) 8.85
Particulars MAR 2023 (Values in Cr)
Revenue 1307.12
Operating Expense 911.07
Net Profit 398.01
Net Profit Margin (%) 30.44
Earnings Per Share (EPS) 29.27
EBITDA 522.38
Effective Tax Rate (%) 8.90
Particulars MAR 2022 (Values in Cr)
Revenue 1193.77
Operating Expense 786.18
Net Profit 417.19
Net Profit Margin (%) 34.94
Earnings Per Share (EPS) 30.70
EBITDA 512.99
Effective Tax Rate (%) 9.01
Particulars MAR 2021 (Values in Cr)
Revenue 1088.65
Operating Expense 729.93
Net Profit 350.61
Net Profit Margin (%) 32.20
Earnings Per Share (EPS) 25.82
EBITDA 427.30
Effective Tax Rate (%) 9.84
Particulars MAR 2020 (Values in Cr)
Revenue 1003.76
Operating Expense 711.36
Net Profit 291.27
Net Profit Margin (%) 29.01
Earnings Per Share (EPS) 21.23
EBITDA 370.32
Effective Tax Rate (%) 9.98
Particulars MAR 2024 (Values in Cr)
Book Value / Share 190.11
ROE % 16.61
ROCE % 12.05
Total Debt to Total Equity 0.76
EBITDA Margin 33.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 161.48
ROE % 18.23
ROCE % 16.68
Total Debt to Total Equity 0.23
EBITDA Margin 31.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 140.36
ROE % 23.29
ROCE % 24.45
Total Debt to Total Equity 0.03
EBITDA Margin 37.94
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.10
ROE % 24.72
ROCE % 26.81
Total Debt to Total Equity 0.00
EBITDA Margin 36.26
Particulars MAR 2020 (Values in Cr)
Book Value / Share 95.47
ROE % 24.24
ROCE % 24.80
Total Debt to Total Equity 0.07
EBITDA Margin 35.74
Particulars MAR 2024 (Values in Cr)
Book Value / Share 185.55
ROE % 12.63
ROCE % 9.98
Total Debt to Total Equity 0.60
EBITDA Margin 31.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 163.39
ROE % 19.23
ROCE % 19.94
Total Debt to Total Equity 0.08
EBITDA Margin 38.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 141.11
ROE % 23.88
ROCE % 25.68
Total Debt to Total Equity 0.00
EBITDA Margin 42.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.03
ROE % 24.39
ROCE % 26.48
Total Debt to Total Equity 0.00
EBITDA Margin 38.55
Particulars MAR 2020 (Values in Cr)
Book Value / Share 95.72
ROE % 23.72
ROCE % 24.21
Total Debt to Total Equity 0.07
EBITDA Margin 36.31
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1400.63
Total Assets 7048.83
Total Liabilities 7048.83
Total Equity 3222.03
Share Outstanding 136028280
Price to Book Ratio 4.53
Return on Assets (%) 5.56
Return on Capital (%) 6.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.45
Total Assets 3667.32
Total Liabilities 3667.32
Total Equity 2220.67
Share Outstanding 135992238
Price to Book Ratio 3.50
Return on Assets (%) 10.42
Return on Capital (%) 12.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.32
Total Assets 2272.13
Total Liabilities 2272.13
Total Equity 1908.20
Share Outstanding 135930197
Price to Book Ratio 4.88
Return on Assets (%) 17.87
Return on Capital (%) 20.79
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 38.27
Total Assets 1834.78
Total Liabilities 1834.78
Total Equity 1576.42
Share Outstanding 135780653
Price to Book Ratio 5.21
Return on Assets (%) 19.35
Return on Capital (%) 22.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 67.32
Total Assets 1552.30
Total Liabilities 1552.30
Total Equity 1296.33
Share Outstanding 135780653
Price to Book Ratio 3.85
Return on Assets (%) 19.10
Return on Capital (%) 22.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1296.73
Total Assets 5349.56
Total Liabilities 5349.56
Total Equity 2524.02
Share Outstanding 136028280
Price to Book Ratio 4.53
Return on Assets (%) 5.60
Return on Capital (%) 5.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 47.64
Total Assets 2783.65
Total Liabilities 2783.65
Total Equity 2221.88
Share Outstanding 135992238
Price to Book Ratio 3.50
Return on Assets (%) 14.29
Return on Capital (%) 15.68
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 46.10
Total Assets 2150.41
Total Liabilities 2150.41
Total Equity 1918.55
Share Outstanding 135930197
Price to Book Ratio 4.88
Return on Assets (%) 19.40
Return on Capital (%) 21.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 32.65
Total Assets 1754.80
Total Liabilities 1754.80
Total Equity 1575.46
Share Outstanding 135780653
Price to Book Ratio 5.21
Return on Assets (%) 19.97
Return on Capital (%) 22.25
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 64.95
Total Assets 1483.12
Total Liabilities 1483.12
Total Equity 1299.70
Share Outstanding 135780653
Price to Book Ratio 3.85
Return on Assets (%) 19.63
Return on Capital (%) 22.41
Particulars MAR 2024 (Values in Cr)
Net Income 431.23
Cash from Operations 586.75
Cash from Investing -1854.52
Cash from Financing 1379.77
Net change in Cash 11.26
Free Cash Flow 715.92
Particulars MAR 2023 (Values in Cr)
Net Income 404.64
Cash from Operations 368.94
Cash from Investing -982.10
Cash from Financing 688.02
Net change in Cash -2.33
Free Cash Flow 1210.36
Particulars MAR 2022 (Values in Cr)
Net Income 442.19
Cash from Operations 461.54
Cash from Investing -319.61
Cash from Financing -44.69
Net change in Cash 13.95
Free Cash Flow 582.58
Particulars MAR 2021 (Values in Cr)
Net Income 394.49
Cash from Operations 443.89
Cash from Investing -323.35
Cash from Financing -82.39
Net change in Cash -30.39
Free Cash Flow 469.65
Particulars MAR 2020 (Values in Cr)
Net Income 331.35
Cash from Operations 322.93
Cash from Investing 123.23
Cash from Financing -334.59
Net change in Cash 59.80
Free Cash Flow 474.21
Particulars MAR 2024 (Values in Cr)
Net Income 328.83
Cash from Operations 409.77
Cash from Investing -2491.89
Cash from Financing 2160.05
Net change in Cash 4.45
Free Cash Flow 758.81
Particulars MAR 2023 (Values in Cr)
Net Income 436.91
Cash from Operations 400.11
Cash from Investing -513.29
Cash from Financing 193.74
Net change in Cash 2.77
Free Cash Flow 711.37
Particulars MAR 2022 (Values in Cr)
Net Income 458.53
Cash from Operations 452.31
Cash from Investing -267.63
Cash from Financing -88.42
Net change in Cash 13.35
Free Cash Flow 505.59
Particulars MAR 2021 (Values in Cr)
Net Income 388.89
Cash from Operations 463.44
Cash from Investing -347.86
Cash from Financing -81.12
Net change in Cash -33.58
Free Cash Flow 489.06
Particulars MAR 2020 (Values in Cr)
Net Income 323.59
Cash from Operations 315.58
Cash from Investing 126.73
Cash from Financing -333.52
Net change in Cash 58.46
Free Cash Flow 464.30
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1489.50
  • 26 Days 1431.70
  • 10 Days 1481.70
  • 50 Days 1397.00
  • 12 Days 1481.90
  • 100 Days 1319.30
  • 20 Days 1448.80
  • 200 Days 916.50
1514.82
PIVOT
First Resistance 1529.63
Second Resistance 1546.37
Third Resistance 1561.18
First Support 1498.08
Second Support 1483.27
Third Support 1466.53
RSI 56.23
MACD 50.14
Commodity Channel Index (CCI) 43.27
ADX 59.60
Williams % R -66.62

Over 1 Month

down

10.21

Over 3 Months

down

5.20

Over 6 Months

down

43.16

Over 1 Year

down

68.44

Over 3 Years

down

27.32

Over 5 Years

down

25.93

ERIS LIFESCIENCES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ERIS LIFESCIENCES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
18.47
Promoter Holdings
54.87
FII
8.01
DII
18.64
Promoter Shares(Pledge Percentage)
18.51
Name Category Shares Shares%
Amit Indubhusan Bakshi Shareholding of Promoter and Promoter Group 5.8335144E7 42.86
Hdfc Small Cap Fund Public Shareholding 1.0261281E7 7.54
Lilac Investments Limited Public Shareholding 9886882.0 7.26
Inderjeet Singh Negi Shareholding of Promoter and Promoter Group 5939833.0 4.36
Rajendrakumar Rambhai Patel Shareholding of Promoter and Promoter Group 5939834.0 4.36
Uti Flexi Cap Fund Public Shareholding 5191243.0 3.81
Franklin India Smaller Companies Fund Public Shareholding 4892053.0 3.59
Kaushal Kamleshkumar Shah Shareholding of Promoter and Promoter Group 4468833.0 3.28
Rakesh Shah Public Shareholding 3975981.0 2.92
Hetal Rasiklal Shah Public Shareholding 3000000.0 2.2
Bhikhalal Chimanlal Shah Public Shareholding 2680000.0 1.97
Amit Bakshi Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Inreal Ventures Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Shah & Co. Shareholding of Promoter and Promoter Group 0.0 0.0
Mrudang Hiren Vakil (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Kaushal Kamlesh Shah (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Kamlesh Rasiklal Shah (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Pragnesh Bharatkumar Shah (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Pragnesh Bharatkumar Shareholding of Promoter and Promoter Group 0.0 0.0
Pinky Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Alpana Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Bakulaben Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Bharatbhai Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Saanvi Kaushal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Karmm Kaushal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Kajal Mrudang Vakil Shareholding of Promoter and Promoter Group 0.0 0.0
Shilpaben Kamleshkumar Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Kamleshkumar Rasiklal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Sweta Kaushal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Rajendrakumar Rambhai Patel Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Hetal Bholabhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Jagdish Bholabhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Ambaben Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Dhyanvi Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Parthiv Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Sanjay Rambhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Chandrikaben Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Shardaben Rambhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Parul Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Tresna Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Cinta Medtech Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Happynings Lifeskills Llp Earlier Known As Footlights Theaters Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Indubhushan Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Eris Lifesciences Private Limited Group Gratuity Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Eris Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Horizon Blue Ventures Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Amit Bakshi (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Amit Somnat Mehrotra Shareholding of Promoter and Promoter Group 0.0 0.0
Shashi Somnat Shareholding of Promoter and Promoter Group 0.0 0.0
Somnat Mehrotra Shareholding of Promoter and Promoter Group 0.0 0.0
Parv Amit Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Gauri Sachin Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Nira Indubhushan Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Indubhushan Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Rangoli Amit Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Inderjeet Singh Negi Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Upender Singh Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Sandeepa Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Rameshwari Devi Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Shiv Chanran Singh Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Aditi Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Manvendra Singh Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Asha Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Rekha Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeshwari Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Sateshwari Devi Shareholding of Promoter and Promoter Group 0.0 0.0
Suman Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Sarthak Negi Shareholding of Promoter and Promoter Group 100.0 0.0

ERIS LIFESCIENCES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2022-08-11 7.35 Interim 2022-08-16 Equity shares 2021-08-05 6.01 Interim 2021-08-06 Equity shares 2020-08-13 5.5 Interim 2020-08-14 Equity shares 2020-03-19 2.87 Interim 2020-03-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ERIS LIFESCIENCES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ERIS LIFESCIENCES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of ERIS Lifesciences Ltd?

Answer Field

The share price of ERIS Lifesciences Ltd for NSE is ₹ 1475 and for BSE is ₹ 1480.9.

What is the Market Cap of ERIS Lifesciences Ltd?

Answer Field

The market cap of ERIS Lifesciences Ltd for NSE is ₹ 2,00,64.17 Cr. and for BSE is ₹ 2,01,44.43 Cr. as of now.

What is the 52 Week High and Low of ERIS Lifesciences Ltd?

Answer Field

The 52 Week High and Low of ERIS Lifesciences Ltd for NSE is ₹ 1593.90 and ₹ 809.15 and for BSE is ₹ 1593.00 and ₹ 810.10.

How to Buy ERIS Lifesciences Ltd share?

Answer Field

You can trade in ERIS Lifesciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for ERIS Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 68.44%.

What is the Current Share Price of ERIS Lifesciences Ltd?

Answer Field

ERIS Lifesciences Ltd share price is for NSE ₹ 1475 & for BSE ₹ 1480.9 as on Dec 13 2024 03:29 PM.

What is the Market Cap of ERIS Lifesciences Ltd Share?

Answer Field

The market cap of ERIS Lifesciences Ltd for NSE ₹ 2,00,64.17 & for BSE ₹ 2,01,44.43 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of ERIS Lifesciences Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for ERIS Lifesciences Ltd share is 171.63.

What is the PB ratio of ERIS Lifesciences Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for ERIS Lifesciences Ltd share is 189.32.

How to Buy ERIS Lifesciences Ltd Share?

Answer Field

You can trade in ERIS Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy ERIS Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy ERIS Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “ERIS Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader